Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Lenvatinib yields high response rates and delays progression in radioiodine...
Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France
Lenvatinib yields high response rates and delays progression in radioiodine-resistant, advanced differentiated thyroid cancer ( Prof Martin Schlumberger - Institut Gustave Roussy, Villejuif, France )
31 May 2014
Second-line treatment with ramucirumab plus docetaxel extends survival in...
Dr Maurice Pérol - Centre Léon Bérard, Lyon, France
Second-line treatment with ramucirumab plus docetaxel extends survival in advanced NSCLC ( Dr Maurice Pérol - Centre Léon Bérard, Lyon, France )
31 May 2014
Cediranib plus olaparib significantly increases PFS in recurrent ovarian cancer
Dr Joyce Liu - Dana-Farber Cancer Institute, Boston, USA
Cediranib plus olaparib significantly increases PFS in recurrent ovarian cancer ( Dr Joyce Liu - Dana-Farber Cancer Institute, Boston, USA )
31 May 2014
Ibrutinib significantly delays disease progression and extends survival in...
Dr John Byrd - The Ohio State University, Columbus, USA
Ibrutinib significantly delays disease progression and extends survival in resistant or relapsed CLL ( Dr John Byrd - The Ohio State University, Columbus, USA )
31 May 2014
Emerging pathways in immunotherapy
Prof Christopher Höller - Medical University of Vienna, Vienna, Austria
Emerging pathways in immunotherapy ( Prof Christopher Höller - Medical University of Vienna, Vienna, Austria )
20 May 2014
Checkpoint blockade: a concept or already a reality?
Prof Paolo Ascierto - National Cancer Institute 'Foundazione G. Pascale'...
Checkpoint blockade: a concept or already a reality? ( Prof Paolo Ascierto - National Cancer Institute 'Foundazione G. Pascale', Naples, Italy )
20 May 2014
Cancer evasion of the immune system: the fundamentals
Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland
Cancer evasion of the immune system: the fundamentals ( Prof Pedro Romero - Ludwig Institute for Cancer Research, Lausanne, Switzerland )
20 May 2014
New rules for clinical trials
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
New rules for clinical trials ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
20 May 2014
ecancermedicalscience Editor's Choice for May 2014
Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for May 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
20 May 2014
Myeloma genomics and Immuno-oncology
Prof Keith Stewart; Prof Gareth Morgan; Dr Leif L. Bergsagel; Prof Antonio...
Myeloma genomics and Immuno-oncology ( Prof Keith Stewart; Prof Gareth Morgan; Dr Leif L. Bergsagel; Prof Antonio Palumbo )
15 May 2014
Novel targets and immune based therapy in myeloma
Dr Kenneth Anderson; Prof Antonio Palumbo; Prof Gareth Morgan; Prof Jesús San...
Novel targets and immune based therapy in myeloma ( Dr Kenneth Anderson; Prof Antonio Palumbo; Prof Gareth Morgan; Prof Jesús San Miguel )
15 May 2014
Upcoming trends in myeloma therapy
Dr Kenneth Anderson; Prof Gareth Morgan; Prof Paul Richardson
Upcoming trends in myeloma therapy ( Dr Kenneth Anderson; Prof Gareth Morgan; Prof Paul Richardson )
15 May 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation